PEDS exam 3 Flashcards
(108 cards)
Congenital hypothyroidism
Failure of thyroid gland to migrate during fetal development
Low T3 and T4
If untreated=intellectual disability, delayed physical maturation, short stature and growth failure
Early identification=KEY
Physical cues-Congenital hypothyroidism
Poor sucking reflex, hypothermia, constipation, lethargy/hypotonia, preorbital puffiness, cool dry and scaly skin, bradycardia, RR distress, large fontnelles, delayed closure fontanelles, macroglossia, course facial features
Diagnostics (labs)-Congenital hypothyroidism
Low T3 and free T4(0.8-2.4ng/dL)
High TSH
Medications-Congenital hypothyroidism
L-thyroxine(Sythroid, Levothroid)
Medication management-Congenital hypothyroidism
Pill only- must be crushed and placed in 1-2 mL milk via bottle nipple or dropper
Missed doses may lead to developmental delay/poor growth
Teaching-Congenital hypothyroidism
Medication absorption affected by soy-based formulas, fiber, calcium, iron preparations, and antacids
Thyroid function tests to monitor
Growth hormone deficiency
Failure of anterior pituitary gland to produce sufficient GH or failure of hypothalamus to stimulate anterior pituitary gland. Impairs body’s metabolism of proteins, fat, carbs
-caused by injury to hypothalamus or pituitary gland
Cause of GH deficiency
Injury to pituitary gland or hypothalamus
-tumors, infection, infarction, CNS irradiation, congenital abnormalities, birth trauma, emotional depravation
Physical cues-Growth hormone deficiency
Large/prominent forehead, under developed jaw, high-pitched voice, delayed sexual maturation, delayed dentition/skeletal maturation, decreased muscle mass
Diagnostics-Growth hormone deficiency
Skeletal survey= 2+SD<normal in bone age
CT/MRI- tumors/rule out abnormalities
Pituitary function test to confirm
Medications-Growth hormone deficiency
Bio synthetic GH via Sub-Q injections
-0.18-0.3 mg/kg/week divided into equal daily doses
Medication management-Growth hormone deficiency
Monitor for s/e of meds
Monitor effectiveness of hormone replacement(measure height Q3-6 mo
-continued until growth rate of less than 1 in/yr or bone age >16(boys) or >14 (girls)
Type 1 DM
Deficient insulin secretion due to pancreatic beta cells damage
-quicker onset, autoimmune, Dx at younger age
Diagnostics-Type 1 DM
Blood sugar(and fasting glucose) and chemical panel, CBC, UA, oral GTT
Expected lab findings-Type 1 DM
BS>200mg/dL
Fasting glucose >126mg/dL
HbA1C:>6.5%
Chem panel: evaluate BUN/creatinine, Ca+, Mg+, PO4-, Na+
UA- presence of ketones and glucose
Oral GTT >200mg/dL at 2 hrs
Hypoglycemia s/s
Shakiness, lightheadedness, hunger, pallor, cool skin, diaphoresis, irritability, anxiety, slurred speech, tachycardia, palpitations, normal/shallow RR , seizures leading to coma, dec LOC
Hypoglycemia management
BS <60mg/mL
If child coherent- feels s/s hypo
-give glucose tab/15g of simple CHO (OJ/milk), followed by complex CHO(PB and crackers)
Incoherent:glucagon Sub-Q or IM
-under 20kg=give 0.5mg
-over 20kg= give 1 mg
-D50 IV PRN
Hyperglycemia S/S
Mental/behavior changes, weakness, fatigue, polyuria, polydipsia, polyphagia, HA, enuresis, blurred vision
Insulin types
Rapid acting,Short acting, intermediate acting, long acting
Rapid acting insulin
Novolog(aspart), Humalog(Lispro)
Short acting insulin
Regular (Humulin R, Novolin R)
Intermediate acting insulin
NPH(Humulin N, Novolin N)
Long acting insulin
Glargine(Lantus)DO NOT MIX, detemir(levemir), degludec (Tresiba)
Proper insulin administration
Sub-Q, self administer 2 times or more/day. rotating sites Q 4-6 injections. 2 in from Umbilicus=best absorption.
Draw up short acting (clear) first then longer-acting insulin (cloudy)
-90 degree angle, pinch up skin if thin